Opendata, web and dolomites

EBODAC SIGNED

Communication strategy and tools for optimizing the impact of Ebola vaccination deployment – Sofia ref.: 115847

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "EBODAC" data sheet

The following table provides information about the project.

Coordinator
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER 

Organization address
address: KEPPEL STREET
city: LONDON
postcode: WC1E 7HT
website: http://www.lshtm.ac.uk/

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.ebovac.org/ebodac/
 Total cost 20˙402˙786 €
 EC max contribution 20˙328˙856 € (100%)
 Programme 1. H2020-EU.3.1.7. (Innovative Medicines Initiative 2 (IMI2))
 Code Call H2020-JTI-IMI2-2014-02-single-stage
 Funding Scheme IMI2-RIA
 Starting year 2014
 Duration (year-month-day) from 2014-12-01   to  2020-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER UK (LONDON) coordinator 3˙380˙902.00
2    WORLD VISION OF IRELAND LBG IE (DUBLIN 6) participant 13˙493˙437.00
3    GRAMEEN FOUNDATION USA US (WASHINGTON) participant 3˙454˙515.00
4    JANSSEN PHARMACEUTICA NV BE (BEERSE) participant 0.00

Map

 Project objective

Communication strategy and tools for optimizing the impact of Ebola vaccination deployment.

The EBODAC consortium consists of 4 partners: Janssen (EFPIA), London School of Hygiene and Tropical Medicine (LSHTM), World Vision of Ireland and Grameen Foundation . These partners have experience and expertise in:

• (Ebola) vaccine development and vaccine acceptance; m-health deployments for disease management in resource limited settings (Janssen) • Vaccine acceptance; risk management in health programs (LSHTM) • Mobile health deployments for emergency assistance; communication and training delivery in emergency settings (World Vision) • Mobile health software development and deployment in resource limited settings (Grameen)

As such, the EBODAC consortium is well placed to tackle the challenges associated with Ebola vaccine deployment, including: • Stigma related to Ebola infections • Lack of understanding and distrust versus vaccines in general in the local endemic communities • Two step prime/booster regimen for Ebola vaccine: risk for a ‘no show’ for the booster shot, risk for presenting for the booster shot too early or too late; risk for a different person presenting for the booster shot vs. the prime shot • People may be difficult to reach for the vaccine recall; People may live at a large distance from the health center where the vaccine is delivered • Risk for data on vaccine coverage to be fragmented, not existing or incorrect

The EBODAC consortium is committed to deliver: • A communication strategy that will optimize vaccine acceptance, supported by local anthropology research data • A platform, based on mobile phone technology, for Ebola vaccine recalls, information/education on Ebola and vaccines in general; and tracking of vaccination coverage • An identification tool to allow to match the identity of individuals in the prime and boost vaccine regimens • A training program in the local setting, and a helpdesk function, to support the m-health platform

 Deliverables

List of deliverables.
Test identification tool ready (for trial) Demonstrators, pilots, prototypes 2019-11-15 10:09:01
Final platform ready (trial) Other 2019-11-15 10:09:01
Technology components integrated (trial) Other 2019-11-15 10:09:01
All privacy, regulatory and policy elements taken into account for trial (for each geography) Documents, reports 2019-11-15 10:09:01
Technical deployment elements ready (trial)(for each geography) Other 2019-11-15 10:09:01
Iris-Scan study including data Documents, reports 2019-11-15 10:09:01
Content for Mobile Training and Support Service for health;workers ready Documents, reports 2019-11-15 10:09:01
Message content developed for trial Documents, reports 2019-11-15 10:09:01
Overview of data flow (for trial) Documents, reports 2019-11-15 10:09:01
Test platform ready (trial) Demonstrators, pilots, prototypes 2019-11-15 10:09:01

Take a look to the deliverables list in detail:  detailed list of EBODAC deliverables.

 Publications

year authors and title journal last update
List of publications.
2019 Serge Masyn, Anneleen Vuchelen, Eva Santermans, Freya Rasschaert, Allieu Bangura, Wim Parys, Romain Rutten
Overcoming the challenges of iris scanning to identify minors (1–4 years) in the real-world setting
published pages: , ISSN: 1756-0500, DOI: 10.1186/s13104-019-4485-8
BMC Research Notes 12/1 2020-03-05
2019 Paula Mc Kenna, Geoffrey Babughirana, Monica Amponsah, Seth Gogo Egoeh, Evelyne Banura, Robert Kanwagi, Bobbi Gray
Mobile training and support (MOTS) service—using technology to increase Ebola preparedness of remotely-located community health workers (CHWs) in Sierra Leone
published pages: 35-35, ISSN: 2306-9740, DOI: 10.21037/mhealth.2019.09.03
mHealth 5 2020-03-05
2017 Geoffrey Babughirana, Robert Kanwagi (World Vision)
Making enabling technologies work in Prime-Boost vaccination programs
published pages: , ISSN: , DOI:
2019-11-15
2016 Luisa Enria, Shelley Lees, Elizabeth Smout, Thomas Mooney, Angus F. Tengbeh, Bailah Leigh, Brian Greenwood, Deborah Watson-Jones, Heidi Larson
Power, fairness and trust: understanding and engaging with vaccine trial participants and communities in the setting up the EBOVAC-Salone vaccine trial in Sierra Leone
published pages: , ISSN: 1471-2458, DOI: 10.1186/s12889-016-3799-x
BMC Public Health 16/1 2019-11-15
2017 Per Egil Kummervold, William S. Schulz, Elizabeth Smout, Luis Fernandez-Luque, Heidi J. Larson
Controversial Ebola vaccine trials in Ghana: a thematic analysis of critiques and rebuttals in digital news
published pages: , ISSN: 1471-2458, DOI: 10.1186/s12889-017-4618-8
BMC Public Health 17/1 2019-11-15

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EBODAC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EBODAC" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.7.)

AB-DiRecT (2019)

Antibiotic Distribution and Recovery in Tissue

Read More  

RespiriNTM (2019)

Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs

Read More  

GNA NOW (2019)

NOVEL GRAM-NEGATIVE ANTIBIOTIC NOW

Read More